Skip to main content
Sophie Lanzkron, MD, Hematology, Baltimore, MD, Johns Hopkins Hospital

SophieMiriamLanzkronMD

Hematology • Baltimore, MD

Professor of Medicine, Professor of Oncology, Johns Hopkins University School of Medicine

Join to view full profile

Dr. Lanzkron is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lanzkron's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1994 - 1996
  • University of Maryland
    University of MarylandResidency, Internal Medicine, 1991 - 1994
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 1991

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1994 - 2024
  • TX State Medical License
    TX State Medical License 1997 - 2000
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Correction to: Do Words Matter? Stigmatizing Language and the Transmission of Bias in the Medical Record  
    Sophie Lanzkron, Monica E Peek, Mary Catherine Beach, Anna P Goddu, Somnath Saha, Mustapha O Saheed, Journal of General Internal Medicine
  • A Phase 3 Trial of L-glutamine in Sickle Cell Disease  
    Rita Bellevue, Joseph L Lasky, Elliott P Vichinsky, Lewis L Hsu, Sharada Sarnaik, Lynne D Neumayr, Yutaka Niihara, Sophie Lanzkron, Ifeyinwa Osunkwo, Lance Sieger, Edu..., The New England Journal of Medicine

Abstracts/Posters

  • Standard Definitions of Pneumococcal Immunity May Not Accurately Predict Protection in Adults with Sickle Cell Disease
    Sophie M. Lanzkron, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Anti-Mullerian Hormone, a Measure of Ovarian Reserve, Is Low in Female Subjects in the Multi-Center Study of Hydroxyurea
    Sophie M. Lanzkron, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Quality Improvement Initiative: Improving Time to First Dose in a Sickle Cell Infusion Center
    Sophie M. Lanzkron, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Sickle Cell Disease 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Special Education Session on ASH Clinical Practice Guidelines on Sickle Cell Disease 
    60th American Society of Hematology Annual Meeting - 12/2/2018
  • Special Education Session on ASH Clinical Practice Guidelines on Sickle Cell Disease 
    60th American Society of Hematology Annual Meeting - 12/1/2018
  • Join now to see all

Press Mentions

  • Doi: 10.32481/djph.2022.10.004
    Doi: 10.32481/djph.2022.10.004October 1st, 2022
  • Sickle Cell Patients Face a Double Whammy: Systemic Racism and a Crippling Disease
    Sickle Cell Patients Face a Double Whammy: Systemic Racism and a Crippling DiseaseJune 7th, 2022
  • Sickle Cell Disease Tied to COVID-19 Mortality, Hospitalizations
    Sickle Cell Disease Tied to COVID-19 Mortality, HospitalizationsJuly 21st, 2021
  • Join now to see all

Hospital Affiliations

External Links

Dr. Sophie Lanzkron, Dr. Sophie Lanzkron, MD, Dr. S Lanzkron, Dr. Sophie Miriam Lanzkron